Investing Ideas
/
Peruvian Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Peruvian Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

1 companies

Bayer (Peru)

Market Cap: S/294.5m

Engages in the pharmaceuticals, consumer health, and crop science businesses in Peru.

BAYERI1

S/20.00

41.8%